Profile data is unavailable for this security.
About the company
OptiBiotix Health Plc is a life sciences company. The Company is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements. It is focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. It is also developing its own range of consumer supplements and health products. Its areas of focus include obesity, cardiovascular health, and diabetes. Its products include SlimBiome, CholBiome, SweetBiotix, WellBiome, OptiBiotics and SlimBiome X3. SlimBiome offers a natural, scientifically supported, non-pharmaceutical approach to reducing hunger and cravings. CholBiome contains Lactobacillus plantarum LPLDL as the only active ingredient, focusing on healthy cholesterol maintenance and delivering tangible health benefits. SweetBiotix is a zero or low-calorie, prebiotic, and a smarter alternative to sugar and existing sweeteners.
- Revenue in GBP (TTM)1.15m
- Net income in GBP-191.00k
- Incorporated2006
- Employees5.00
- LocationOptiBiotix Health PLCInnovation CentreInnovation Way, HeslingtonHESLINGTON Y010 5DGUnited KingdomGBR
- Phone+44 207 933 8780
- Websitehttp://www.optibiotix.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roquefort Therapeutics PLC | 0.00 | -882.45k | 1.80m | 1.00 | -- | 0.3644 | -- | -- | -0.0063 | -0.0063 | 0.00 | 0.0302 | 0.00 | -- | -- | 0.00 | -15.04 | -- | -17.23 | -- | -- | -- | -- | -- | -- | -17.40 | 0.0747 | -- | -100.00 | -- | 44.29 | -- | -- | -- |
| ValiRx Plc | 49.78k | -1.78m | 2.56m | 14.00 | -- | 0.3742 | -- | 51.48 | -0.0094 | -0.0094 | 0.0002 | 0.0092 | 0.0147 | 0.00 | 0.6068 | 3,555.71 | -55.35 | -48.98 | -51.45 | -49.62 | 100.00 | -- | -3,775.95 | -16,086.59 | 8.87 | -- | 0.0022 | -- | 418.54 | -- | 5.99 | -- | -37.39 | -- |
| N4 Pharma PLC | 7.07k | -1.07m | 3.95m | 4.00 | -- | 2.24 | -- | 559.17 | -0.0025 | -0.0025 | 0.00002 | 0.0021 | 0.0045 | -- | 0.0756 | 1,767.50 | -71.04 | -59.59 | -74.91 | -63.90 | -- | -- | -15,981.33 | -67,987.22 | -- | -- | 0.00 | -- | 273.33 | -- | 16.60 | -- | -- | -- |
| TheraCryf PLC | 0.00 | -2.01m | 4.51m | 9.00 | -- | 0.9398 | -- | -- | -0.0017 | -0.0017 | 0.00 | 0.0022 | 0.00 | -- | -- | 0.00 | -41.20 | -38.70 | -53.79 | -42.97 | -- | -- | -- | -1,407.46 | -- | -- | 0.00 | -- | -100.00 | -- | 38.13 | -- | -- | -- |
| Cizzle Biotechnology Holdings PLC | 0.00 | -1.12m | 6.14m | 67.00 | -- | -- | -- | -- | -0.0028 | -0.0028 | 0.00 | -0.0007 | 0.00 | -- | -- | -- | -190.34 | -146.14 | -433.59 | -169.40 | -- | -- | -- | -- | 0.4766 | -2.42 | -- | -- | -- | -- | -26.15 | -- | -- | -- |
| Talisman Metals PLC | 0.00 | 65.26k | 6.75m | 1.00 | -- | 2.82 | 103.48 | -- | -0.0064 | -0.016 | 0.00 | 0.0373 | 0.00 | -- | -- | 0.00 | 3.15 | -30.40 | 3.64 | -33.15 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 99.94 | -- | -- | -- |
| OptiBiotix Health PLC | 1.15m | -191.00k | 7.90m | 5.00 | -- | 0.9385 | 564.46 | 6.87 | -0.0018 | -0.0018 | 0.0113 | 0.0815 | 0.134 | 1.93 | 2.88 | 230,200.00 | -2.22 | 17.23 | -2.33 | 17.84 | 45.44 | 50.78 | -16.59 | 189.34 | 3.75 | -- | 0.00 | 94.93 | 35.09 | 3.15 | 11.48 | -- | -- | -- |
| Futura Medical PLC | 7.93m | -6.29m | 8.14m | 12.00 | -- | 1.40 | -- | 1.03 | -0.0207 | -0.0207 | 0.0261 | 0.01 | 1.06 | 137.36 | 8.58 | -- | -84.19 | -45.00 | -112.42 | -71.79 | 70.67 | -- | -79.41 | -108.25 | 2.21 | -- | 0.00 | -- | 349.09 | 237.55 | 119.85 | -- | 121.02 | -- |
| IXICO PLC | 6.53m | -1.65m | 9.50m | 79.00 | -- | 0.8093 | -- | 1.45 | -0.0186 | -0.0186 | 0.073 | 0.1267 | 0.5222 | -- | 3.18 | 82,708.86 | -13.19 | -3.47 | -15.43 | -4.03 | 48.71 | 55.52 | -25.27 | -6.21 | -- | -- | 0.015 | -- | 13.32 | -7.27 | 17.49 | -- | -5.30 | -- |
| Genflow Biosciences PLC | 0.00 | -1.80m | 10.36m | 5.00 | -- | -- | -- | -- | -0.005 | -0.005 | 0.00 | -0.0007 | 0.00 | -- | -- | 0.00 | -197.92 | -- | -648.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.68 | -- | -- | -- |
| Solvonis Therapeutics PLC | 0.00 | -2.60m | 17.70m | -- | -- | 2.22 | -- | -- | -0.001 | -0.001 | 0.00 | 0.0012 | 0.00 | -- | -- | -- | -44.49 | -- | -54.32 | -- | -- | -- | -- | -- | -- | -645.25 | 0.011 | -- | -100.00 | -- | 53.62 | -- | -- | -- |
| Fusion Antibodies PLC | 1.60m | -1.47m | 19.69m | 24.00 | -- | 24.66 | -- | 12.34 | -0.0144 | -0.0144 | 0.0152 | 0.0064 | 0.9557 | 4.96 | 1.96 | 66,500.00 | -87.84 | -56.24 | -137.88 | -73.67 | 22.06 | 36.41 | -91.92 | -71.05 | 1.45 | -190.63 | 0.3483 | -- | 72.98 | -12.79 | 23.05 | -- | -37.98 | -- |
| Sareum Holdings Plc | 0.00 | -4.44m | 23.47m | 5.00 | -- | 10.04 | -- | -- | -0.0365 | -0.0365 | 0.00 | 0.0169 | 0.00 | -- | -- | 0.00 | -126.85 | -93.37 | -202.14 | -118.41 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -29.77 | -- | -- | -- |
Data as of Feb 10 2026. Currency figures normalised to OptiBiotix Health PLC's reporting currency: UK Pound GBX
23.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| KW Investment Management Ltd.as of 17 Apr 2025 | 10.31m | 9.98% |
| Hargreaves Lansdown Fund Managers Ltd.as of 17 Apr 2025 | 4.79m | 4.64% |
| Alumni Capital Management LLCas of 24 Jun 2025 | 3.04m | 2.94% |
| IG Markets Ltd.as of 17 Apr 2025 | 2.06m | 2.00% |
| HSBC Global Asset Management (UK) Ltd.as of 17 Apr 2025 | 1.70m | 1.65% |
| Rathbones Investment Management Ltd.as of 17 Apr 2025 | 1.28m | 1.23% |
| HSBC Bank Plc (Market-Maker)as of 17 Apr 2025 | 380.00k | 0.37% |
| iDealing.com Ltd.as of 17 Apr 2025 | 377.00k | 0.37% |
| Winterflood Securities Ltd (Market-Maker)as of 17 Apr 2025 | 274.00k | 0.27% |
| Jarvis Investment Management Ltd.as of 17 Apr 2025 | 263.00k | 0.26% |
More ▼
Data from 31 Mar 2025 - 02 Feb 2026Source: FactSet Research Systems Inc.
